Oral contraceptive use: Impact on folate, vitamin B 6, and vitamin B 12 status

Nutrition Reviews

Volumn 69, Issue 10, 2011, Pages 572-583

  Wilson, Stephanie M C ^a   Bivins, Brittney N ^b   Russell, Katelyn A ^a   Bailey, Lynn B ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Folate; Oral contraceptives; Vitamin B 12; Vitamin B 6

Indexed keywords

CYANOCOBALAMIN; ESTROGEN; FOLIC ACID; MESTRANOL PLUS NORETYNODREL; ORAL CONTRACEPTIVE AGENT; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE;

ARTICLE; CYANOCOBALAMIN DEFICIENCY; DRUG EFFECT; DRUG EXCRETION; DRUG MECHANISM; EVENING DOSAGE; FOLIC ACID DEFICIENCY; HUMAN; LOW DRUG DOSE; MATERNAL NUTRITION; NEURAL TUBE DEFECT; NEUROLOGIC DISEASE; PREGNANCY; PREGNANCY OUTCOME; PYRIDOXINE DEFICIENCY; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

CONTRACEPTION; CONTRACEPTIVES, ORAL; EVIDENCE-BASED MEDICINE; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL STATUS; PREGNANCY; VITAMIN B 12 DEFICIENCY; VITAMIN B 6 DEFICIENCY;

EID: 80053498716     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00419.x     Document Type: Article

References (147)

1. United Nations. World Contraceptive Use 2009. Department of Economic and Social Affairs, Population Division; 2009. Available at
2. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004;350:1-36.
3. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90-96.
4. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception. 2008;77:10-21.
5. Potter L, Oakley D, de Leon-Wong E, Canamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect. 1996;28:154-158.
6. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995;51:283-288.
7. Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med. 1995;40:355-360.
8. Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006;83:993-1016.
9. Wallis D, Ballard JL, Shaw GM, Lammer EJ, Finnell RH. Folate-related birth defects: embroyonic consequences of abnormal folate transport and metabolism. Bailey LB, ed. Folate in Health and Disease, 2nd ed. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2009:155-178.
10. Gerstman BB, Gross TP, Kennedy DL, Bennett RC, Tomita DK, Stadel BV. Trends in the content and use of oral contraceptives in the United States, 1964-88. Am J Public Health. 1991;81:90-96.
11. Diczfalusy E. The history of steroidal contraception: what is past and what is present? Diczfalusy E, ed. The Contraceptive Revolution: An Era of Scientific and Social Development. Pearl River, NY: Parthenon Publishing Group; 1997:117-132.
12. Ortho Pharmaceuticals. Ortho: a her-story of achievement in women's health. Women's Health Care. 2006;5:16-20.
13. 12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. Eur J Obstet Gynecol Reprod Biol. 2003;107:57-61.
14. Piper JM, Kennedy DL. Oral contraceptives in the United States: trends in content and potency. Int J Epidemiol. 1987;16:215-221.
15. American Society of Health-System Pharmacists I. Estrogen and Progestin (Oral Contraceptives ). 2010:Available at: Accessed 20 August 2010.
16. Clinical Pharmacology. Contraceptives 2010:Available at: Accessed 20 August 2010.
17. Stover P. Folate biochemical pathways and their regulation. Bailey LB, ed. Folate in Health and Disease, 2nd ed. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2009:49-74.
18. Kauwell GPA, Diaz ML, Yang Q, Bailey LB. Folate: recommended intakes, consumption, and status. Bailey LB, ed. Folate in Health and Disease, 2nd ed. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2009:467-490.
19. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341:1509-1519.
20. Smithells R, Nevin N, Seller M, etal. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1983;321:1027-1031.
21. Laurence K, James N, Miller M, Tennant G, Campbell H. Double-blinded randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J (Clin Res Ed). 1981;282:1509-1511.
22. Seller MJ, Nevin NC. Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet. 1984;21:325-330.
23. Berry RJ, Li Z, Erickson JD, etal. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485-1490.
24. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
25. Hobbs CA, Shaw GM, Werler MM, Mosley B. Folate status and birth defect risk: epidemiological perspective. Bailey LB, ed. Folate in Health and Disease, 2nd ed. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2009:133-154.
26. Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr. 2005;81(Suppl):S1213-S1217.
27. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ. 2009;338:b1673.
28. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981-2986.
29. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995;346:393-396.
30. 12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
31. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41:1-7.
32. Institute of Medicine. DRI, Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, DC: National Academies Press; 2006.
33. Green-Raleigh K, Carter H, Mulinare J, Prue C, Petrini J. Trends in folic acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995-2005. Matern Child Health J. 2006;10(Suppl):S177-S182.
34. Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med. 2010;38:534-542.
35. Holmes RP. Megaloblastic anemia precipitated by the use of oral contraceptive. A case report. N C Med J. 1970;31:17-18.
36. Trowbridge M Jr, Wadsworth RC, Moffitt E. Malabsorption associated with gluten enteropathy, do oral contraceptives interfere with folate metabolism? J Maine Med Assoc. 1968;59:240-242.
37. Paton A. Oral contraceptives and folate deficiency. Lancet. 1969;293:418.
38. Ryser JE, Farquet JJ, Petite J. Megaloblastic anemia due to folic acid deficiency in a young woman on oral contraceptives. Acta Haematol. 1971;45:319-324.
39. Whitehead N, Reyner F, Lindenbaum J. Megaloblastic changes in the cervical epithelium. Association with oral contraceptive therapy and reversal with folic acid. JAMA. 1973;226:1421-1424.
40. Shojania AM, Hornady G, Barnes PH. Oral contraceptives and serum-folate level. Lancet. 1968;291:1376-1377.
41. McLean FW, Heine MW, Held B, Streiff RR. Relationship between the oral contraceptive and folic acid metabolism. Serum folate concentrations. Am J Obstet Gynecol. 1969;104:745-747.
42. Castren OM, Rossi RR. Effect of oral contraceptives on serum folic acid content. J Obstet Gynaecol Br Commonw. 1970;77:548-550.
43. Pritchard JA, Scott DE, Whalley PJ. Maternal folate deficiency and pregnancy wastage. IV. Effects of folic acid supplements, anticonvulsants, and oral contraceptives. Am J Obstet Gynecol. 1971;109:341-346.
44. 12 in women using oral contraceptives compared to non-users. Thromb Res. 2003;112:37-41.
45. 12 to bone mineral density of postmenopausal women. Bone. 2003;33:956-959.
46. 12 and folate metabolism in women taking oral contraceptive agents. S Afr Med J. 1974;48:1937-1940.
47. Ahmed F, Bamji MS, Iyengar L. Effect of oral contraceptive agents on vitamin nutrition status. Am J Clin Nutr. 1975;28:606-615.
48. Smith JL, Goldsmith GA, Lawrence JD. Effects of oral contraceptive steroids on vitamin and lipid levels in serum. Am J Clin Nutr. 1975;28:371-376.
49. Paine CJ, Grafton WD, Dickson VL, Eichner ER. Oral contraceptives, serum folate, and hematologic status. JAMA. 1975;231:731-733.
50. Mooij PN, Thomas CM, Doesburg WH, Eskes TK. Multivitamin supplementation in oral contraceptive users. Contraception. 1991;44:277-288.
51. Steegers-Theunissen RP, Van Rossum JM, Steegers EA, Thomas CM, Eskes TK. Sub-50 oral contraceptives affect folate kinetics. Gynecol Obstet Invest. 1993;36:230-233.
52. 12 binding capacity and oral contraceptive hormones. J Clin Endocrinol Metab. 1969;29:1425-1428.
53. Shojania AM, Hornady GJ, Scaletta D. The effect of oral contraceptives on folate metabolism. III. Plasma clearance and urinary folate excretion. J Lab Clin Med. 1975;85:185-190.
54. Lindenbaum J, Whitehead N, Reyner F. Oral contraceptive hormones, folate metabolism, and the cervical epithelium. Am J Clin Nutr. 1975;28:346-353.
55. Butterworth CE Jr, Krumdieck CL, Stinson HN, Cornwell PE. A study of the effect of oral contraceptive agents on the absorption, metabolic conversion and urinary excretion of a naturally-occurring folate (citrovorum factor). Ala J Med Sci. 1975;12:330-335.
56. Chalmers DM, Levi AJ, Chanarin I, North WR, Meade TW. Mean cell volume in a working population: the effects of age, smoking, alcohol and oral contraception. Br J Haematol. 1979;43:631-636.
57. Amatayakul K, Uttaravichai C, Singkamani R, Ruckphaopunt S. Vitamin metabolism and the effects of multivitamin supplementation in oral contraceptive users. Contraception. 1984;30:179-196.
58. Henriquez P, Doreste J, Diaz-Cremades J, Lopez-Blanco F, Alvarez-Leon E, Serra-Majem L. Folate status of adults living in the Canary Islands (Spain). Int J Vitam Nutr Res. 2004;74:187-192.
59. Green TJ, Houghton LA, Donovan U, Gibson RS, O'Connor DL. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. J Am Diet Assoc. 1998;98:49-55.
60. Pietarinen GJ, Leichter J, Pratt RF. Dietary folate intake and concentration of folate in serum and erythrocytes in women using oral contraceptives. Am J Clin Nutr. 1977;30:375-380.
61. 12, and folic acid. Am J Obstet Gynecol. 1976;125:1063-1069.
62. Prasad AS, Oberleas D, Moghissi KS, Lei KY, Stryker JC. Effect of oral contraceptive agents on nutrients: I. Minerals. Am J Clin Nutr. 1975;28:377-384.
63. Martinez OB, Roe DA. Lack of effect of norethindrone and mestranol on folacin depletion and repletion in rats. J Nutr. 1977;107:1157-1169.
64. 12 levels and on tryptophan metabolism in baboons. Am J Clin Nutr. 1975;28:354-362.
65. Christensen KE, Rozen R. Genetic variation: effect on folate metabolism and health. Bailey LB, ed. Folate in Health and Disease, 2nd ed. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2009:75-110.
66. Streiff RR. Folate deficiency and oral contraceptives. JAMA. 1970;214:105-108.
67. Necheles TF, Snyder LM. Malabsorption of folate polyglutamates associated with oral contraceptive therapy. N Engl J Med. 1970;282:858-859.
68. Stephens ME, Craft J, Peters TJ, Hoffbrand AV. Oral contraceptives and folate metabolism. Clin Sci. 1972;42:405-414.
69. Shojania AM, Hornady GJ. Oral contraceptives and folate absorption. J Lab Clin Med. 1973;82:869-875.
70. Da Costa M, Rothenberg SP. Appearance of a folate binder in leukocytes and serum of women who are pregnant or taking oral contraceptives. J Lab Clin Med. 1974;83:207-214.
71. Scott JM. Catabolism of folates. Blakley RL, Whitehead VM, eds. Folates and Pterins. New York, NY: John Wiley & Sons; 1984:307-327.
72. Caudill MA, Gregory JF, Hutson AD, Bailey LB. Folate catabolism in pregnant and nonpregnant women with controlled folate intakes. J Nutr. 1998;128:204-208.
73. Bailey LB. Folic acid. Zempleni J, Rucker RB, McCormick DB, Suttie JW, eds. Handbook of Vitamins. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2007:385-412.
74. Maxwell JD, Hunter J, Stewart DA, Ardeman S, Williams R. Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction? Br Med J. 1972;1:297-299.
75. 12 and folic acid binding proteins in women taking oral contraceptives. Southeast Asian J Trop Med Public Health. 1977;8:480-485.
76. 12 metabolism. Can Med Assoc J. 1982;126:244-247.
77. 6 deficiency in infants; a follow-up study. AMA Am J Dis Child. 1955;90:344-348.
78. Snyderman SE, Holt LE Jr, Carretero R, Jacobs K. Pyridoxine deficiency in the human infant. J Clin Nutr. 1953;1:200-207.
79. 6 deficiency with convulsions in infants. Public Health Rep. 1956;71:445-448.
80. 6 depletion of young, nonpregnant women. Am J Clin Nutr. 1991;53:1266-1274.
81. 6 deficiency on specific regions of developing rat braamino acid metabolism. J Nutr. 1983;113:735-745.
82. 6 deficiency on specific regions of developing rat brathe extrapyramidal motor system. J Nutr. 1983;113:746-754.
83. 6 deficiency. Ann NY Acad Sci. 1990;585:202-218.
84. Candito M, Rivet R, Herbeth B, etal. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet. 2008;146A:1128-1133.
85. Aycock JE, Kirksey A. Influence of different levels of dietary pyridoxine on certain parameters of developing and mature brains in rats. J Nutr. 1976;106:680-688.
86. 6 intake, levels of the vitamin in biological fluids, and condition of the infant at birth. Am J Clin Nutr. 1979;32:2249-2256.
87. Ronnenberg AG, Venners SA, Xu X, etal. Preconception B-vitamin and homocysteine status, conception, and early pregnancy loss. Am J Epidemiol. 2007;166:304-312.
88. Ronnenberg AG, Goldman MB, Chen D, etal. Preconception folate and vitamin B(6) status and clinical spontaneous abortion in Chinese women. Obstet Gynecol. 2002;100:107-113.
89. Ronnenberg AG, Goldman MB, Chen D, etal. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr. 2002;76:1385-1391.
90. 12, Pantothenic Acid, Biotin and Choline. Washington, D.C.: National Academy Press; 1998.
91. Lumeng L, Cleary RE, Li TK. Effect of oral contraceptives on the plasma concentration of pyridoxal phosphate. Am J Clin Nutr. 1974;27:326-333.
92. 6 status indices are lower in pregnant than in nonpregnant women but urinary excretion of 4-pyridoxic acid does not differ. J Nutr. 1993;123:2137-2141.
93. 6 supplementation during pregnancy: a prospective study. Am J Clin Nutr. 1976;29:1376-1383.
94. Rose DP. The influence of oestrogens on tryptophan metabolism in man. Clin Sci. 1966;31:265-272.
95. 6 metabolism in users of oral contraceptive agents. I. Abnormal urinary xanthurenic acid excretion and its correction by pyridoxine. Am J Clin Nutr. 1971;24:684-693.
96. Price JM, Thornton MJ, Mueller LM. Tryptophan metabolism in women using steroid hormones for ovulation control. Am J Clin Nutr. 1967;20:452-456.
97. 6 metabolism. Am J Clin Nutr. 1971;24:297-303.
98. 6: a status report. J Nutr. 1990;120(Suppl):S1503-S1507.
99. Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008;87:1446-1454.
100. 6 requirements of women using oral contraceptives. Am J Clin Nutr. 1975;28:535-541.
101. 6 requirement and oral contraceptive use - a concern? J Nutr. 1986;116:475-477.
102. 6 status. Contraception. 1989;40:377-384.
103. 6 nutriture during pregnancy and lactation. II. The effect of long-term use of oral contraceptives. Am J Clin Nutr. 1979;32:2257-2264.
104. 6. Acta Vitaminol Enzymol. 1982;4:45-54.
105. 6, and pyridoxic acid levels in urine. Am J Clin Nutr. 1979;32:1024-1032.
106. 6 requirement in oral contraceptive users. I. Assessment by pyridoxal level and transferase activity in erythrocytes. Am J Clin Nutr. 1979;32:1015-1023.
107. 6. Am J Clin Nutr. 1975;28:10-19.
108. 6 status. Clin Chim Acta. 1973;49:195-199.
109. 6 status. Studies on pregnant women and oral contraceptive users. Am J Clin Nutr. 1975;28:739-747.
110. Braidman IP, Rose DP. The effect of sex hormones on the activity of tryptophan oxygenase and other corticosteroid-inducible enzymes in rat liver. Biochem J. 1971;122:28P.
111. Bender DA, Wynick D. Inhibition of kynureninase (L-kynurenine hydrolase, EC 3 7. 1 3) by oestrone sulphate: an alternative explanation for abnormal results of tryptophan load tests in women receiving oestrogenic steroids. Br J Nutr. 1981;45:269-275.
112. 6. Br J Nutr. 1999;81:7-20.
113. Rose DP, Adams PW. Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone. J Clin Pathol. 1972;25:252-258.
114. 6 requirements in women. Acta Vitaminol Enzymol. 1975;29:151-157.
115. Pepys MB, Hirschfield GM. C-reactive protea critical update. J Clin Invest. 2003;111:1805-1812.
116. Krintus M, Sypniewska G, Kuligowska-Prusinska M. Effect of second- and third-generation oral contraceptives on C-reactive protein, lipids and apolipoproteins in young, non-obese, non-smoking apparently healthy women. Clin Biochem. 2010;43:626-628.
117. Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obest Relat Metab Disord. 2004;28:998-1003.
118. Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J. Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 2001;103:2788-2791.
119. Morris MS, Sakakeeny L, Jacques PF, Picciano MF, Selhub J. Vitamin B-6 intake is inversely related to, and thee requirement is affected by, inflammation status. J Nutr. 2010;140:103-110.
120. Cheng CH, Lin PT, Liaw YP, etal. Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease. Nutrition. 2008;24:239-244.
121. Quasim T, McMillan DC, Talwar D, Vasilaki A, St J O'Reilly D, Kinsella J. The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients. Clin Nutr. 2005;24:956-960.
122. Gray A, McMillan DC, Wilson C, Williamson C, O'Reilly DS, Talwar D. The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phosphate following elective knee arthroplasty. Clin Nutr. 2004;23:1080-1083.
123. 6. Arthritis Res Ther. 2005;7:R1254-R1262.
124. 12. Zempleni J, Rucker RB, McCormick DB, Suttie JW, eds. Handbook of Vitamins, 4th ed. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2007:413-458.
125. 12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev. 2008;66:250-255.
126. 12 deficiency during lactation on maternal and infant health. Adv Exp Med Biol. 2002;503:57-67.
127. 12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr Bull. 2008;29(Suppl):S101-S111; discussion S112-115.
128. 12 deficiency in infants. J Pediatr. 1992;121:710-714.
129. 12 deficiency in infancy. Arch Dis Child. 1997;77:137-139.
130. 12 are independent risk factors for neural tube defects. Q J Med. 1993;86:703-708.
131. 12 insufficiency and the risk of fetal neural tube defects. QJM. 2003;96:289-295.
132. 12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol. 2004;191:11-17.
133. 12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology. 2007;18:362-366.
134. 12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol. 2003;13:81-88.
135. 12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics. 2009;123:917-923.
136. Adams MJ Jr, Khoury MJ, Scanlon KS, etal. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology. 1995;51:311-317.
137. Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part II - vitamin D, vitamin A, iron, zinc, iodine, essential fatty acids. J Matern Fetal Neonatal Med. 2011;24(1):1-24.
138. Riedel B, Bjorke Monsen AL, Ueland PM, Schneede J. Effects of oral contraceptives and hormone replacement therapy on markers of cobalamin status. Clin Chem. 2005;51:778-781.
139. 12 metabolism. Am J Obstet Gynecol. 1979;135:129-134.
140. 12 levels with oral contraceptive use. JAMA. 1972;221:1371-1374.
141. Brattstrom L, Israelsson B, Olsson A, Andersson A, Hultberg B. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scand J Clin Lab Invest. 1992;52:283-287.
142. Wynn V. Vitamins and oral contraceptive use. Lancet. 1975;305:561-564.
143. Gardyn J, Mittelman M, Zlotnik J, Sela BA, Cohen AM. Oral contraceptives can cause falsely low vitamin B(12) levels. Acta Haematol. 2000;104:22-24.
144. 12 deficiency? Eur J Obstet Gynecol Reprod Biol. 2004;115:240-241; author reply 241-242.
145. 12-binding protein levels associated with oral contraceptives. Tex Rep Biol Med. 1978;36:69-77.
146. 12, folic acid and their binding proteins during pregnancy. Acta Haematol. 1985;74:92-96.
147. Koebnick C, Heins UA, Dagnelie PC, etal. Longitudinal concentrations of vitamin B(12) and vitamin B(12)-binding proteins during uncomplicated pregnancy. Clin Chem. 2002;48:928-933.